Clinical study on the effect of Chinese herbal medicine on high-risk population of COVID-19

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2022
INTERVENTION: Treatment group:Chinese medicine preventive granule (high dose);Control group:Chinese medicine preventive granule (low dose); CONDITION: Corona Virus Disease 2019 PRIMARY OUTCOME: Positive rate of virus nucleic acid test; SECONDARY OUTCOME: Rate of symptoms;rate of severe disease; INCLUSION CRITERIA: 1. Close and sub‐close contacts of COVID‐19 infected persons; 2. Aged 5‐80 years; 3. Informed consent of patients.
Epistemonikos ID: 8cc59f864d187ba84fb20135c2e4c17a5d2a083d
First added on: Jun 30, 2022